Neurochem Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 06-12-2024
- Paid Up Capital ₹ 0.50 M
as on 06-12-2024
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.00 M
as on 06-12-2024
- Revenue 32.16%
(FY 2021)
- Profit 44.64%
(FY 2021)
- Ebitda 27.14%
(FY 2021)
- Net Worth 38.21%
(FY 2021)
- Total Assets 21.12%
(FY 2021)
About Neurochem Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹6.00 M.
Hemant Vij, Rajesh Vij, and Tilak Vij serve as directors at the Company.
- CIN/LLPIN
U24233UP2012PTC053677
- Company No.
053677
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Neurochem Laboratories Private Limited offer?
Neurochem Laboratories Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Micronutrient Fertilizers, Dyes & Color Additives, Paint Additives, Chemical Reagents & Catalysts, Potassium Salts, White Pigments, Common Disease Medicines, Antihistamines.
Who are the key members and board of directors at Neurochem Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Vij  | Director | 16-Nov-2012 | Current |
| Hemant Vij | Director | 16-Nov-2012 | Current |
| Tilak Vij | Director | 09-Jan-2015 | Current |
Financial Performance of Neurochem Laboratories.
Neurochem Laboratories Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 32.16% increase. The company also saw a substantial improvement in profitability, with a 44.64% increase in profit. The company's net worth Soared by an impressive increase of 38.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neurochem Laboratories?
In 2021, Neurochem Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Nov 2017 | ₹6.00 M | Open |
How Many Employees Work at Neurochem Laboratories?
Unlock and access historical data on people associated with Neurochem Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neurochem Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neurochem Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
